Can NVO Defend Its Obesity Lead as GLP-1 Competition Intensifies?
Novo Nordisk faces slowing semaglutide momentum as new obesity contenders, including GPCR's aleniglipron, push the competitive landscape forward.
Zacks·6h ago
More News
A Closer Look at Structure Therapeutics's Options Market Dynamics
read more...
Benzinga·1d ago
Structure Therapeutics (NASDAQ:GPCR) Sees Strong Trading Volume - What's Next?
Structure Therapeutics (NASDAQ:GPCR) Sees Strong Trading Volume - Here's Why...
MarketBeat·1d ago
GPCR Stock Soars 102% on Strong Phase II Obesity Data for Aleniglipron
Structure Therapeutics jumps after phase II data show aleniglipron delivering strong, durable weight-loss results across multiple studies.
Zacks·1d ago
GPCR Stock Soars 102% on Strong Phase II Obesity Data for Aleniglipron
Structure Therapeutics jumps after phase II data show aleniglipron delivering strong, durable weight-loss results across multiple studies.
Zacks·1d ago
Why Structure Therapeutics Stock Doubled and Then Some on Monday
Key PointsShareholders were extremely pleased by the biotech's latest news from the lab...
Nasdaq News: Markets·2d ago
Mid Cap Stocks To Watch Today - December 8th
WAVE Life Sciences, ProShares UltraPro Short QQQ, AltC Acquisition, Direxion Daily TSLA Bull 2X Shares, and Structure Therapeutics are the five Mid Cap stocks to watch today, according to...
MarketBeat·2d ago
Pharmaceutical Stocks To Follow Today - December 8th
Eli Lilly and Company, Structure Therapeutics, and Pfizer are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of...
MarketBeat·2d ago
Medical Stocks To Watch Today - December 8th
WAVE Life Sciences, Eli Lilly and Company, and Structure Therapeutics are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly...
MarketBeat·2d ago
What's Going On With Structure Therapeutics (GPCR) Stock Today?
Shares of Structure Therapeutics are soaring Monday after the company reported positive topline data from a weight loss drug trial.read more...